- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02919228
Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 4 of 7)
Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach
NOTE: This is the fourth of in total 7 sub-studies related to the Ethics Committee of the Canton of Bern Ref. No. KEK-BE 2016-00674. This sub-study includes 50 participants and 8 arms, in total 350 participants will be assessed in all 7 sub-studies.
General study information: This is a randomized, cross-over, quantitative study, which investigates physiological variables, mood, and affect of healthy participants in response to colored light exposure. The Participants take part in 5-8 arms and are exposed to colored light only, or are additionally asked to solve cognitive tasks during the colored light exposure. Primary aim is to measure the change in several physiological variables, mood, and affect during colored light exposure of 15 or 45 minutes. The risk for the participants is negligible and comparable to the risk during daily life.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, 3012
- University of Bern, Institute of Complementary Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Normal color vision
- Right handed
- Written informed consent
Exclusion Criteria:
- Smoking
- Any kind of diagnosed sleep disorder or neurological or psychiatric disorder in the last 3 months
- Acute severe traumas
- Chronic diseases with the necessity for medication
- Use of recreational drugs
- Regular intake of medication that would affect the outcome measures
- Regular excessive alcohol use (> 18 standard units / week)
- Transmeridian travel in the last month (crossed > 1 time zone border)
- Night shift word during the last month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Visible light exposure cognitive Red
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to red LED light at a fixed illuminance for 15 minutes.
The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness.
The participants will additionally perform hyperventilation and hypoventilation tasks.
|
Subjects will be exposed to visible colored light for 15 minutes.
The visible light will be generated by red-green-blue light emitting diodes light cans.
|
|
Experimental: Visible light exposure cognitive Orange
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to orange LED light at a fixed illuminance for 15 minutes.
The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness.
The participants will additionally perform hyperventilation and hypoventilation tasks.
|
Subjects will be exposed to visible colored light for 15 minutes.
The visible light will be generated by red-green-blue light emitting diodes light cans.
|
|
Experimental: Visible light exposure cognitive Yellow
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to yellow LED light at a fixed illuminance for 15 minutes.
The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness.
The participants will additionally perform hyperventilation and hypoventilation tasks.
|
Subjects will be exposed to visible colored light for 15 minutes.
The visible light will be generated by red-green-blue light emitting diodes light cans.
|
|
Experimental: Visible light exposure cognitive Green
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to green LED light at a fixed illuminance for 15 minutes.
The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness.
The participants will additionally perform hyperventilation and hypoventilation tasks.
|
Subjects will be exposed to visible colored light for 15 minutes.
The visible light will be generated by red-green-blue light emitting diodes light cans.
|
|
Experimental: Visible light exposure cognitive Cyan
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to cyan LED light at a fixed illuminance for 15 minutes.
The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness.
The participants will additionally perform hyperventilation and hypoventilation tasks.
|
Subjects will be exposed to visible colored light for 15 minutes.
The visible light will be generated by red-green-blue light emitting diodes light cans.
|
|
Experimental: Visible light exposure cognitive Blue
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to blue LED light at a fixed illuminance for 15 minutes.
The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness.
The participants will additionally perform hyperventilation and hypoventilation tasks.
|
Subjects will be exposed to visible colored light for 15 minutes.
The visible light will be generated by red-green-blue light emitting diodes light cans.
|
|
Experimental: Visible light exposure cognitive Violet
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to violet LED light at a fixed illuminance for 15 minutes.
The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness.
The participants will additionally perform hyperventilation and hypoventilation tasks.
|
Subjects will be exposed to visible colored light for 15 minutes.
The visible light will be generated by red-green-blue light emitting diodes light cans.
|
|
Experimental: Visible light exposure cognitive White
The participants will be tested for cognitive performance (verbal fluency task, arithmetic task, word repetition task) during exposure to white LED light at a fixed illuminance for 15 minutes.
The colored light exposure will be preceded by sitting 8 minutes in darkness and followed by sitting 20 minutes in darkness.
The participants will additionally perform hyperventilation and hypoventilation tasks.
|
Subjects will be exposed to visible colored light for 15 minutes.
The visible light will be generated by red-green-blue light emitting diodes light cans.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in cerebral tissue oxygen saturation during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
|
|
Change in variables of the heart rate variability during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
|
|
Change in variables of the electro-dermal activity during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
|
|
Change of the blood pressure during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
|
|
Change of the partial pressure of carbon dioxide during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
|
|
Change of the respiration rate during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
|
|
Change of the heart rate during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
|
|
Change of the pulse-respiratory quotient during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
The pulse-respiratory quotient will be calculated as heart rate divided by the respiration rate.
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
|
Change of the arterial oxygen saturation during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
|
|
Change in cerebral hemoglobin concentrations during colored light exposure compared with a baseline and a recovery period
Time Frame: 43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
43 minutes (8 min baseline, 15 min colored light exposure, 20 min recovery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in verbal fluency task performance during exposure to different colors.
Time Frame: 1-4 weeks
|
A word repetition task will serve as control condition.
|
1-4 weeks
|
|
Change in arithmetic task performance during exposure to different colors.
Time Frame: 1-4 weeks
|
A word repetition task will serve as control condition.
|
1-4 weeks
|
|
Difference in brain activity evoked from the verbal fluency task for the different colored light conditions.
Time Frame: 1-4 weeks
|
A word repetition task will serve as control condition.
|
1-4 weeks
|
|
Difference in brain activity evoked from the arithmetic task for the different colored light conditions.
Time Frame: 1-4 weeks
|
A word repetition task will serve as control condition.
|
1-4 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ursula Wolf, Prof. Dr., University of Bern
Publications and helpful links
General Publications
- Weinzirl J, Wolf M, Nelle M, Heusser P, Wolf U. Colored light and brain and muscle oxygenation. Adv Exp Med Biol. 2012;737:33-6. doi: 10.1007/978-1-4614-1566-4_5. No abstract available.
- Weinzirl J, Wolf M, Heusser P, Nelle M, Wolf U. Effects of changes in colored light on brain and calf muscle blood concentration and oxygenation. ScientificWorldJournal. 2011 Jun 9;11:1216-25. doi: 10.1100/tsw.2011.118.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- COLOR10_d
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.